PCRX vs TEL · P/E 174, rev $369.8M vs P/E 39, rev $17.26B
Pacira BioSciences, Inc. (PCRX) versus TE Connectivity Ltd (TEL) — a side-by-side from cached financials, not a winner call.
Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
TE Connectivity Ltd (TEL) is a electronic components company listed on US.
Latest reported PCRX revenue for 2026-06-30 was $369.8M. Net income was $7.6M. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
Latest reported TEL revenue for 2025-09-26 was $17.26B. Net income was $1.84B. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
PCRX currently screens at market cap $890.8M and trailing P/E 174.2. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
Not investment advice. Open the PCRX and TEL stock pages for the full models.
Not investment advice.